G. Riemekasten

The impact of malnutrition on quality of life in patients with systemic sclerosis

E. Cereda, A. Makowka, K. Franz, 2018, European Journal of Clinical Nutrition.

2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

M. Vonk, R. Naden, Y. Allanore, 2013, Arthritis and rheumatism.

[Raynaud phenomenon in dermatology. Part 1: Pathophysiology and diagnostic approach].

G. Riemekasten, C. Sunderkötter, Cord Sunderkötter, 2006, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

There is a need for new systemic sclerosis subset criteria. A content analytic approach

Shervin, M. Baron, A. Gabrielli, 2018, Scandinavian journal of rheumatology.

Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres

A. Gabrielli, L. Czirják, D. Farge, 2011, Annals of the rheumatic diseases.

The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase‐1 antibodies

M. Worm, G. Riemekasten, T. Krieg, 2016, The British journal of dermatology.

Large Variability of Frequency and Type of Physical Therapy in Patients in the German Network for Systemic Sclerosis

U. Müller-Ladner, M. Worm, N. Hunzelmann, 2020, Arthritis care & research.

[Iloprost administration over 21 days as an effective therapy in systemic scleroderma--case report and review of the literature].

G. Burmester, G. Riemekasten, F. Hiepe, 1998, Zeitschrift fur Rheumatologie.

Vasoactive Therapy in Systemic Sclerosis: Real-life Therapeutic Practice in More Than 3000 Patients

Manfred, Matthias Schneider, S. Karrer, 2017 .